Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes
Open Access
- 7 April 2022
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 3 (4) , 100598
Abstract
No abstract availableKeywords
Funding Information
- NIDDK Division of Diabetes Endocrinology and Metabolic Diseases (DK074970, DK107444)
- National Institutes of Health (2UC4DK098085)
- National Institute of Diabetes and Digestive and Kidney Diseases (SCR _014387)
- U.S. Department of Veterans Affairs (BX003725)
- Indiana University (9,127,088)
This publication has 37 references indexed in Scilit:
- Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetesDiabetologia, 2012
- Pitstop 2 Is a Potent Inhibitor of Clathrin-Independent EndocytosisPLOS ONE, 2012
- Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetesJournal of Clinical Investigation, 2011
- Biological and biochemical consequences of global deletion of exon 3 from the ERα geneThe FASEB Journal, 2010
- Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youthTrends in Endocrinology & Metabolism, 2010
- Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human IsletsDiabetes, 2010
- Extranuclear estrogen receptor-α stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesisProceedings of the National Academy of Sciences, 2010
- Importance of Extranuclear Estrogen Receptor-α and Membrane G Protein–Coupled Estrogen Receptor in Pancreatic Islet SurvivalDiabetes, 2009
- Pancreatic Insulin Content Regulation by the Estrogen Receptor ERαPLOS ONE, 2008
- Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in miceProceedings of the National Academy of Sciences, 2006